Hematology journals by time to acceptance (2025)
39 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Hematology Reports | 55 (42–68) | 81 | 5 | ≈$1,956 | Open access (DOAJ) | 0.0 |
| Clinical Lymphoma Myeloma & Leukemia | 59 (43–79) | 219 | 4 | ≈$3,890 | — | 0.0 |
| Mediterranean Journal of Hematology and Infectious Diseases | 60 (35–91) | 67 | 19 | ≈$923 | Open access (DOAJ) | 0.0 |
| European Journal Of Haematology | 61 (43–87) | 155 | 14 | ≈$4,650 | Hybrid | 0.0 |
| American Journal of Hematology | 62 (25–98) | 194 | 18 | ≈$5,450 | — | 0.99 |
| Blood Coagulation & Fibrinolysis | 69 (30–140) | 63 | 35 | — | Hybrid | 0.0 |
| Transplantation and Cellular Therapy | 73 (55–105) | 311 | 6 | ≈$3,650 | — | 0.0 |
| Blood Research | 74 (51–106) | 55 | 23 | $2,290 | Open access (DOAJ) | 0.0 |
| Blood Reviews | 81 (63–94) | 56 | 3 | ≈$5,220 | Hybrid | 0.0 |
| eJHaem | 82 (38–124) | 207 | 32 | $3,150 | Open access (DOAJ) | 0.0 |
| Thrombosis Research | 84 (63–119) | 165 | 3 | ≈$4,080 | Hybrid | 0.0 |
| Transfusion | 90 (62–156) | 363 | 17 | ≈$4,100 | — | 0.0 |
| Experimental Hematology | 93 (53–142) | 79 | 12 | ≈$3,250 | — | 0.0 |
| The Lancet Haematology | 95 (53–131) | 102 | — | ≈$7,280 | — | 0.0 |
| Blood Advances | 101 (65–140) | 721 | — | $4,000 | Open access (DOAJ) | 0.0 |
| Annals of Hematology | 101 (68–166) | 567 | 22 | $4,590 | Open access (DOAJ) | 0.0 |
| British Journal of Haematology | 101 (76–131) | 522 | 15 | ≈$5,190 | — | 0.0 |
| Research and Practice in Thrombosis and Haemostasis | 101 (54–142) | 320 | 8 | $2,990 | Open access (DOAJ) | 0.0 |
| Vox Sanguinis | 101 (76–146) | 149 | 22 | ≈$4,150 | — | 0.0 |
| Leukemia Research Reports | 103 (62–144) | 53 | 1 | $1,390 | Open access (DOAJ) | 0.0 |
| International Journal of Hematology | 105 (65–142) | 213 | 13 | ≈$4,390 | Hybrid | 0.0 |
| Blood Vessels Thrombosis & Hemostasis | 105 (78–167) | 83 | 29 | $3,000 | Open access (DOAJ) | — |
| Leukemia Research | 105 (70–145) | 77 | 1 | ≈$3,910 | — | 0.0 |
| Blood Cancer Journal | 107 (77–153) | 107 | 22 | $5,490 | Open access (DOAJ) | 0.0 |
| Transfusion and Apheresis Science | 109 (76–152) | 101 | 2 | ≈$3,160 | — | 0.0 |
| Journal of Thrombosis and Haemostasis | 113 (66–163) | 393 | 16 | ≈$3,750 | Hybrid | 0.0 |
| HemaSphere | 114 (76–155) | 149 | 52 | $2,880 | Open access (DOAJ) | 0.0 |
| International Journal of Laboratory Hematology | 124 (93–162) | 141 | 15 | ≈$3,880 | — | 0.0 |
| Leukemia | 126 (91–179) | 285 | 17 | ≈$5,190 | Hybrid | 0.0 |
| Bone Marrow Transplantation | 126 (86–160) | 146 | 18 | ≈$4,990 | Hybrid | 0.0 |
| Haemophilia | 129 (94–185) | 152 | 20 | ≈$4,760 | — | 0.0 |
| Blood | 134 (84–186) | 483 | — | ≈$5,500 | Hybrid | 0.0 |
| Acta Haematologica | 139 (98–183) | 75 | 20 | — | — | 0.0 |
| Journal of Clinical Apheresis | 141 (91–179) | 71 | — | ≈$3,920 | — | 0.0 |
| Journal of Pediatric Hematology/Oncology | 150 (95–223) | 162 | 40 | — | — | 0.94 |
| Therapeutic Advances in Hematology | 164 (134–194) | 72 | 47 | $2,650 | Open access (DOAJ) | 0.0 |
| Transfusion Medicine | 167 (138–238) | 84 | 13 | ≈$3,700 | — | 0.0 |
| Case Reports in Hematology | 188 (136–269) | 77 | 20 | $960 | Open access (DOAJ) | 0.0 |
| Hematology Transfusion and Cell Therapy | 196 (116–330) | 74 | 86 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Hematology (OpenAlex).
Latest available year: 2024
4 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Seminars in Hematology | 53 (24–82) | 57 | 4 | ≈$4,070 | — | — |
| Blood Neoplasia | 91 (51–138) | 67 | 37 | $3,000 | Open access (DOAJ) | — |
| Indian Journal of Hematology and Blood Transfusion | 111 (72–172) | 205 | 15 | ≈$2,390 | — | 0.0 |
| Journal of Blood Medicine | 118 (90–150) | 58 | 13 | $3,940 | Open access (DOAJ) | 2.79 |
Latest available year: 2022
1 journal without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Asian Journal of Transfusion Science | 104 (48–288) | 106 | 167 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
Latest available year: 2020
3 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Blood Cells Molecules and Diseases | 29 (16–66) | 66 | 4 | ≈$4,030 | — | — |
| Hematology/Oncology and Stem Cell Therapy | 89 (36–153) | 57 | 21 | No fee (DOAJ) | Open access (DOAJ) | — |
| Haematologica | 129 (96–185) | 60 | 340 | ≈$3,462 | Open access (DOAJ) | 0.0 |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Hematology journals accepted papers fastest in 2025?
Among 39 Hematology journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 55 days (Hematology Reports). The middle journal's median was 103 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.